RECORDATI PHARMACEUTICALS LIMITED

05421174
Active Hemel Hempstead

Wholesale of pharmaceutical goods

6 employees website.com
Wholesale of pharmaceutical goods
R

RECORDATI PHARMACEUTICALS LIMITED

05421174

Wholesale of pharmaceutical goods

Founded 11 Apr 2005 Active Hemel Hempstead, England 6 employees website.com
Wholesale of pharmaceutical goods

Previous Company Names

FREDERICK'S PLACE 2081 LIMITED 11 Apr 2005 — 31 May 2005
Accounts Submitted 20 May 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 23 Apr 2026 Next due 25 Apr 2027 10 months remaining
Net assets £13M £594K 2024 year on year
Total assets £16M £957K 2024 year on year
Total Liabilities £3M £363K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Breakspear Park Breakspear Way Hemel Hempstead HP2 4TZ England

Website

www.example.com

Full company profile for RECORDATI PHARMACEUTICALS LIMITED (05421174), an active company based in Hemel Hempstead, England. Incorporated 11 Apr 2005. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 30 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£1.42M

Decreased by £443.32k (-24%)

Net Assets

£13.24M

Increased by £594.44k (+5%)

Total Liabilities

£3.07M

Increased by £362.54k (+13%)

Turnover

£9.68M

Increased by £191.20k (+2%)

Employees

6

Increased by 1 (+20%)

Debt Ratio

19%

Increased by 1 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Recordati Industria Chimica E Farmaceutica S.p.a.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Recordati Industria Chimica E Farmaceutica S.p.a.

Italy

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RECORDATI PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 May 2026OfficersAppointment of Hywel Rhys Day as director on 13 May 2026
23 Apr 2026Confirmation StatementConfirmation statement made on 11 Apr 2026 with no updates
22 Apr 2026OfficersTermination of Sanjay Thomas Verghese as director on 31 Mar 2026
24 Sept 2025OfficersAppointment of Sanjay Thomas Verghese as director on 22 Sept 2025
24 Sept 2025OfficersTermination of Christopher Paul Surridge as director on 22 Sept 2025
15 May 2026 Officers

Appointment of Hywel Rhys Day as director on 13 May 2026

23 Apr 2026 Confirmation Statement

Confirmation statement made on 11 Apr 2026 with no updates

22 Apr 2026 Officers

Termination of Sanjay Thomas Verghese as director on 31 Mar 2026

24 Sept 2025 Officers

Appointment of Sanjay Thomas Verghese as director on 22 Sept 2025

24 Sept 2025 Officers

Termination of Christopher Paul Surridge as director on 22 Sept 2025

Recent Activity

Latest Activity

Appointment of Hywel Rhys Day as director on 13 May 2026

1 months ago on 15 May 2026

Confirmation statement made on 11 Apr 2026 with no updates

1 months ago on 23 Apr 2026

Termination of Sanjay Thomas Verghese as director on 31 Mar 2026

1 months ago on 22 Apr 2026

Appointment of Sanjay Thomas Verghese as director on 22 Sept 2025

8 months ago on 24 Sept 2025

Termination of Christopher Paul Surridge as director on 22 Sept 2025

8 months ago on 24 Sept 2025